Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden

被引：0
|
作者：
Santiago Zuluaga-Sanchez
Megan Teynor
Christopher Knight
Robin Thompson
Thomas Lundqvist
Mats Ekelund
Annabelle Forsmark
Adrian D. Vickers
Andrew Lloyd
机构：
[1] RTI Health Solutions,
[2] Biogen Inc,undefined
[3] Biogen International GmbH,undefined
[4] Biogen Sweden,undefined
[5] Nordic Health Economics AB,undefined
[6] Acaster Lloyd Consulting Ltd,undefined
来源：
PharmacoEconomics | 2019年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：845 / 865
页数：20
相关论文
共 50 条
  • [1] Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden
    Zuluaga-Sanchez, Santiago
    Teynor, Megan
    Knight, Christopher
    Thompson, Robin
    Lundqvist, Thomas
    Ekelund, Mats
    Forsmark, Annabelle
    Vickers, Adrian D.
    Lloyd, Andrew
    PHARMACOECONOMICS, 2019, 37 (06) : 845 - 865
  • [2] Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
    Praveen Thokala
    Matt Stevenson
    Varun M. Kumar
    Shijie Ren
    Alexandra G. Ellis
    Richard H. Chapman
    Cost Effectiveness and Resource Allocation, 18
  • [3] Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
    Thokala, Praveen
    Stevenson, Matt
    Kumar, Varun M.
    Ren, Shijie
    Ellis, Alexandra G.
    Chapman, Richard H.
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2020, 18 (01)
  • [4] Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
    Mercuri, E.
    Darras, B. T.
    Chiriboga, C. A.
    Day, J. W.
    Campbell, C.
    Connolly, A. M.
    Iannaccone, S. T.
    Kirschner, J.
    Kuntz, N. L.
    Saito, K.
    Shieh, P. B.
    Tulinius, M.
    Mazzone, E. S.
    Montes, J.
    Bishop, K. M.
    Yang, Q.
    Foster, R.
    Gheuens, S.
    Bennett, C. F.
    Farwell, W.
    Schneider, E.
    De Vivo, D. C.
    Finkel, R. S.
    Bradley, Walter G.
    Kaufmann, Petra
    Dickson, Patricia I.
    Reingold, Stephen C.
    Davis, Charles S.
    Arredondo, Kristen
    Castro, Diana
    Cowie, Margaret
    Farrow-Gillespie, Alan
    Hebert, Andrew
    Kauk, Melissa
    Miller, Nancy
    Nelson, Leslie
    Spain, Thomas, Jr.
    Cappell, Joshua
    Constantinescu, Andrei
    Cruz, Rosangel
    Dastgir, Jahannaz
    De Vivo, Darryl
    Dunaway, Sally
    Engelstad, Kristin
    Khandji, Alexander G.
    Kramer, Samantha
    Marra, Jonathan
    Popolizio, Molly
    Salazar, Rachel
    Weimer, Louis H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (07): : 625 - 635
  • [5] Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
    Finkel, R. S.
    Mercuri, E.
    Darras, B. T.
    Connolly, A. M.
    Kuntz, N. L.
    Kirschner, J.
    Chiriboga, C. A.
    Saito, K.
    Servais, L.
    Tizzano, E.
    Topaloglu, H.
    Tulinius, M.
    Montes, J.
    Glanzman, A. M.
    Bishop, K.
    Zhong, Z. J.
    Gheuens, S.
    Bennett, C. F.
    Schneider, E.
    Farwell, W.
    De Vivo, D. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (18): : 1723 - 1732
  • [6] Long-term benefits of nusinersen in later-onset spinal muscular atrophy
    Ian Fyfe
    Nature Reviews Neurology, 2019, 15 (7) : 368 - 369
  • [7] COST-EFFECTIVENESS OF NUSINERSEN AND ONASEMNOGENE ABEPARVOVEC FOR INFANTILE-ONSET SPINAL MUSCULAR ATROPHY (TYPE I SMA) IN THE US
    Thokala, P.
    Stevenson, M.
    Kumar, V. M.
    Ren, S.
    Chapman, R.
    Ellis, A.
    Rind, D.
    VALUE IN HEALTH, 2019, 22 : S337 - S338
  • [8] Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy
    Montes, Jacqueline
    Young, Sally Dunaway
    Mazzone, Elena S.
    Pasternak, Amy
    Glanzman, Allan M.
    Finkel, Richard S.
    Darras, Basil T.
    Muntoni, Francesco
    Mercuri, Eugenio
    De Vivo, Darryl C.
    Bishop, Kathie M.
    Schneider, Eugene
    Bennett, C. Frank
    Foster, Richard
    Farwell, Wildon
    MUSCLE & NERVE, 2019, 60 (04) : 409 - 414
  • [9] Longer-term treatment with nusinersen: Results in later-onset spinal muscular atrophy from the SHINE study
    Mercuri, E.
    Darras, B.
    Chiriboga, C.
    Farrar, M.
    Kirschner, J.
    Kuntz, N.
    Acsadi, G.
    Tulinius, M.
    Montes, J.
    Gambino, G.
    Foster, R.
    Ramirez-Schrempp, D.
    Garafolo, S.
    Farwell, W.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S121 - S121
  • [10] Nusinersen Treatment of Children with Later-Onset Spinal Muscular Atrophy and Scoliosis Is Associated with Improvements or Stabilization of Motor Function
    Young, Sally Dunaway
    Montes, Jacqueline
    Glanzman, Allan M.
    Gee, Richard
    Day, John W.
    Finkel, Richard S.
    Darras, Basil T.
    De Vivo, Darryl C.
    Gambino, Giulia
    Foster, Richard
    Wong, Janice
    Garafalo, Steve
    Berger, Zdenek
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
12345